- Federal agenciesProvides an evidence base to guide federal and state policymaking on opioid remote monitoring.
- Federal agenciesMay identify cost-saving care models for federal health programs if monitoring improves outcomes.
- Potential benefitCould support expanded insurance coverage or reimbursement for remote monitoring technologies.
Remote Opioid Monitoring Act of 2025
Referred to the House Committee on Energy and Commerce.
The bill requires the Comptroller General (GAO) to study remote monitoring of people prescribed opioids and report to relevant congressional committees within 18 months. The report must assess scientific evidence on efficacy, outcomes, and potential cost savings; estimate current prevalence including international use; and recommend ways to improve availability, access, and coverage, including possible changes to Federal health care programs and identification of beneficiary cohorts.
Privacy vs public-health framing of remote monitoring
Relative to its intended legislative type, this bill is a succinct, functional study mandate: it clearly assigns the Comptroller General to produce a time‑bound report to specified congressional committees on the effects and prevalence of remote monitoring for people prescribed opioids, and it lists specific topics the report must address.
The bill requires the Comptroller General (GAO) to study remote monitoring of people prescribed opioids and report to relevant congressional committees within 18 months.
The report must assess scientific evidence on efficacy, outcomes, and potential cost savings; estimate current prevalence including international use; and recommend ways to improve availability, access, and coverage, including possible changes to Federal health care programs and identification of beneficiary cohorts.
Study-only, low fiscal impact, and public‑health framing favor enactment, though passage still requires floor action in both chambers and signature.
Relative to its intended legislative type, this bill is a succinct, functional study mandate: it clearly assigns the Comptroller General to produce a time‑bound report to specified congressional committees on the effects and prevalence of remote monitoring for people prescribed opioids, and it lists specific topics the report must address.
Privacy vs public-health framing of remote monitoring
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenMay lead to proposals increasing patient surveillance and raising privacy concerns.
- Potential burdenRecommendations could prompt regulatory changes imposing new compliance burdens on providers.
- Potential burdenImplementation could exacerbate inequalities if access to monitoring technology is uneven.
Why the argument around this bill splits.
Privacy vs public-health framing of remote monitoring
Likely supportive because it aims to generate evidence about tools that could reduce opioid harm and expand care access.
Would emphasize equity, privacy, and safeguards to ensure monitoring helps rather than penalizes patients.
Generally favorable as a measured, evidence-gathering step before policy changes.
Wants clear scope, cost estimates, and methodology to avoid unintended consequences or unfunded mandates.
Cautiously receptive to an oversight-style GAO study but wary that 'monitoring' language could presage federal mandates or expanded entitlements.
Emphasizes individual liberty and state control.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Study-only, low fiscal impact, and public‑health framing favor enactment, though passage still requires floor action in both chambers and signature.
- No explicit funding or cost estimate included
- Definition and scope of 'remote monitoring' not specified
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Privacy vs public-health framing of remote monitoring
Study-only, low fiscal impact, and public‑health framing favor enactment, though passage still requires floor action in both chambers and s…
Relative to its intended legislative type, this bill is a succinct, functional study mandate: it clearly assigns the Comptroller General to produce a time‑bound report to specified congressional committees on the effect…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.